Literature DB >> 20298367

The extent of emphysema in patients with COPD.

Saher Burhan Shaker1, Trine Stavngaard, Marianne Hestad, Karen Skjoelstrup Bach, Philip Tonnesen, Asger Dirksen.   

Abstract

BACKGROUND AND AIMS: The global initiative for COPD (GOLD) adopted the degree of airway obstruction as a measure of the severity of the disease. The objective of this study was to apply CT to assess the extent of emphysema in patients with chronic obstructive pulmonary disease (COPD) and relate this extent to the GOLD stage of airway obstruction.
MATERIALS AND METHODS: We included 209 patients with COPD. COPD was defined as FEV(1)/FVC < 0.70 and no reversibility to beta(2)-agonists. All patients were current smokers with a smoking history of >or=20 pack-years. Patients were assessed by lung function measurement and visual and quantitative assessment of CT, from which the relative area of emphysema below -910 Hounsfield units (RA-910) was extracted.
RESULTS: Mean RA-910 was 7.4% (n = 5) in patients with GOLD stage I, 17.0% (n = 119) in stage II, 24.2% (n = 79) in stage III and 33.9% (n = 6) in stage IV. Regression analysis showed a change in RA-910 of 7.8% with increasing severity according to GOLD stage (P < 0.001). Combined visual and quantitative assessment of CT showed that 184 patients had radiological evidence of emphysema, whereas 25 patients had no emphysema.
CONCLUSION: The extent of emphysema increases with increasing severity of COPD and most patients with COPD have emphysema. Tissue destruction by emphysema is therefore an important determinant of disease severity in COPD.

Entities:  

Mesh:

Year:  2009        PMID: 20298367     DOI: 10.1111/j.1752-699X.2008.00102.x

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  5 in total

1.  Correlation Between Emphysema and Lung Function in Healthy Smokers and Smokers With COPD.

Authors:  Laura H Thomsen; Saher B Shaker; Asger Dirksen; Jesper H Pedersen; Ruth Tal-Singer; Per Bakke; Jørgen Vestbo
Journal:  Chronic Obstr Pulm Dis       Date:  2015-05-19

2.  Inhaled Steroids, Sex and Emphysema Index - Clinical Parameters with Impact on the Effectiveness of Valve Implantation in Patients with Severe Emphysema.

Authors:  Markus Polke; Jonas Brugger; Matthias Rötting; Nilab Polke; Judith Brock; Stefanie Schuler; Ines Richter; Ralf Eberhardt; Felix J F Herth; Daniela Gompelmann
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-06-20

3.  Klotho expression is reduced in COPD airway epithelial cells: effects on inflammation and oxidant injury.

Authors:  Wei Gao; Cheng Yuan; Jingying Zhang; Lingling Li; Like Yu; Coen H Wiegman; Peter J Barnes; Ian M Adcock; Mao Huang; Xin Yao
Journal:  Clin Sci (Lond)       Date:  2015-07-10       Impact factor: 6.124

4.  Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?

Authors:  Jakob Löndahl; Jonas Kf Jakobsson; David M Broday; H Laura Aaltonen; Per Wollmer
Journal:  Int J Nanomedicine       Date:  2016-12-19

5.  Airspace Dimension Assessment (AiDA) by inhaled nanoparticles: benchmarking with hyperpolarised 129Xe diffusion-weighted lung MRI.

Authors:  Madeleine Petersson-Sjögren; Ho-Fung Chan; Guilhem J Collier; Graham Norquay; Lars E Olsson; Per Wollmer; Jakob Löndahl; Jim M Wild
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.